[go: up one dir, main page]

JP2001261653A5 - - Google Patents

Download PDF

Info

Publication number
JP2001261653A5
JP2001261653A5 JP2000075518A JP2000075518A JP2001261653A5 JP 2001261653 A5 JP2001261653 A5 JP 2001261653A5 JP 2000075518 A JP2000075518 A JP 2000075518A JP 2000075518 A JP2000075518 A JP 2000075518A JP 2001261653 A5 JP2001261653 A5 JP 2001261653A5
Authority
JP
Japan
Prior art keywords
group
substituted
unsubstituted
mol
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000075518A
Other languages
Japanese (ja)
Other versions
JP2001261653A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2000075518A priority Critical patent/JP2001261653A/en
Priority claimed from JP2000075518A external-priority patent/JP2001261653A/en
Publication of JP2001261653A publication Critical patent/JP2001261653A/en
Publication of JP2001261653A5 publication Critical patent/JP2001261653A5/ja
Pending legal-status Critical Current

Links

Description

【請求項2】
請求項1に記載の一般式(I)で表されるアセチル化合物と下記一般式(III)で表される3−イミノプロペニルアミノ化合物とを反応させる工程を含むことを特徴とするピリジン誘導体の製造方法。
【化3】

Figure 2001261653

式中、R3、R4、R6はそれぞれ独立に水素原子、置換または未置換のアルキル基、置換または未置換のアリ−ル基、置換または未置換のヘテロ環残基、アシル基を表す。R3とR4は結合して、それらが結合している窒素原子と共に非金属原子からなる置換または非置換の環を形成してもよい。R5は、水素原子置換または未置換のアルキル基、置換または未置換のアリ−ル基、置換または未置換のヘテロ環残基、置換または未置換のアルケニル基、置換または未置換のアルキニル基、ヒドロキシル基、アルコキシ基、アリ−ルオキシ基、カルボニル基、スルホニル基、置換または未置換のアミノ基、ニトロ基、シアノ基、ハロゲン原子を表す。 (2)
A method for producing a pyridine derivative, comprising a step of reacting an acetyl compound represented by the general formula (I) according to claim 1 with a 3-iminopropenylamino compound represented by the following general formula (III). Method.
Embedded image
Figure 2001261653

In the formula, R3, R4, and R6 each independently represent a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic residue, or an acyl group. R3 and R4 may combine to form a substituted or unsubstituted ring consisting of a nonmetallic atom together with the nitrogen atom to which they are attached. R5 represents a hydrogen atom , a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heterocyclic residue, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, Represents a hydroxyl group, an alkoxy group, an aryloxy group, a carbonyl group, a sulfonyl group, a substituted or unsubstituted amino group, a nitro group, a cyano group, and a halogen atom.

実施例1 4−メチル−2−(5−メチル−2−ピリジル)ピリジン(V−1)の合成
(2−メチル−3−ピペリジルプロパ−2−エニリデン)ピペリジン過塩素酸塩(IV−1)9.62g(0.03モル)と4−メチル−2−アセチルピリジン4.06g(0.030モル)をテトラヒドロフラン14mlに溶解し、カリウムt−ブトキシド3.63g(0.032モル)を加え60℃で30分間反応した。次いで酢酸アンモニウム9.25g(0.12モル)と酢酸7mlを加え、60℃で2時間反応後、内温を85℃まで上昇させながらテトラヒドロフランを濃縮除去し、85℃で2時間反応した。放冷後、反応液にトルエン40mlと25%NaOH水溶液30mlを加え、トルエン20mlで計4回抽出した。有機層を無水硫酸ナトリウムで乾燥し、それをろ過して濃縮した。トルエンを加えて再結晶し、淡黄色粉末5.53g(収率75.0%)を得た。HPLC分析(カラム ODS−80TM、検出UV 254nm、流量1.0ml/min、溶離液 メタノール/水=40/60 バッファー トリエチルアミンおよび酢酸0.1%)の結果、純度は98.0%であった。融点 170℃〜172℃。
Example 1 Synthesis of 4-methyl-2- (5-methyl-2-pyridyl) pyridine (V-1) (2-methyl-3-piperidylprop-2-enylidene) piperidine perchlorate (IV-1) 9.62 g (0.03 mol) and 4.06 g (0.030 mol) of 4-methyl-2-acetylpyridine were dissolved in 14 ml of tetrahydrofuran, and 3.63 g (0.032 mol) of potassium t-butoxide was added thereto. The reaction was performed at 30 ° C for 30 minutes. Next, 9.25 g (0.12 mol) of ammonium acetate and 7 ml of acetic acid were added, and the mixture was reacted at 60 ° C for 2 hours. Then, tetrahydrofuran was concentrated and removed while the internal temperature was raised to 85 ° C, and the reaction was performed at 85 ° C for 2 hours. After cooling, 40 ml of toluene and 30 ml of a 25% aqueous NaOH solution were added to the reaction solution, and the mixture was extracted four times with 20 ml of toluene. The organic layer was dried over anhydrous sodium sulfate, which was filtered and concentrated. Toluene was added for recrystallization to obtain 5.53 g (yield: 75.0%) of a pale yellow powder. As a result of HPLC analysis (column ODS-80TM, detection UV: 254 nm, flow rate: 1.0 ml / min, eluent: methanol / water = 40/60 buffer, triethylamine and acetic acid: 0.1%), the purity was 98.0%. 170-172 ° C.

Figure 2001261653
Figure 2001261653

JP2000075518A 2000-03-17 2000-03-17 Method for synthesizing pyridine derivative Pending JP2001261653A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000075518A JP2001261653A (en) 2000-03-17 2000-03-17 Method for synthesizing pyridine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000075518A JP2001261653A (en) 2000-03-17 2000-03-17 Method for synthesizing pyridine derivative

Publications (2)

Publication Number Publication Date
JP2001261653A JP2001261653A (en) 2001-09-26
JP2001261653A5 true JP2001261653A5 (en) 2007-06-21

Family

ID=18593400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000075518A Pending JP2001261653A (en) 2000-03-17 2000-03-17 Method for synthesizing pyridine derivative

Country Status (1)

Country Link
JP (1) JP2001261653A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4700916B2 (en) 2004-02-02 2011-06-15 富士フイルムファインケミカルズ株式会社 Method for producing pyridine derivative
US20100016603A1 (en) 2007-01-29 2010-01-21 Fujifilm Finechemicals Co., Ltd. Production process of 2,3'-bipyridyl-6'-one
SMT202000243T1 (en) 2017-03-20 2020-07-08 Forma Therapeutics Inc Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
CN113166060B (en) 2018-09-19 2024-01-09 诺沃挪第克健康护理股份公司 Treatment of sickle cell disease with pyruvate kinase-activating compounds
ES2989438T3 (en) 2018-09-19 2024-11-26 Novo Nordisk Healthcare Ag Activation of pyruvate kinase R
CA3151612A1 (en) 2019-09-19 2021-03-25 George P. Luke Pyruvate kinase r (pkr) activating compositions
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R
CN113354620B (en) * 2021-07-05 2022-03-22 南京桦冠生物技术有限公司 Efficient preparation method of tedizolid intermediate and intermediate thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1178658C (en) * 1998-04-24 2004-12-08 麦克公司 Process for synthesizing Cox-2 inhibitors

Similar Documents

Publication Publication Date Title
JP2834971B2 (en) Method for producing 2- (4-alkoxy-3-cyanophenyl) thiazole derivative and novel intermediate for the production
JP2001261653A5 (en)
WO2003076374A1 (en) PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
JP2668816B2 (en) Process for producing benzothiadiazole derivative
JPS63145286A (en) Bicyclic imidazole derivative
JP3448635B2 (en) Sulfenamide compound and method for producing the same
JP5279449B2 (en) Process for producing 5- {4- [2- (5-ethyl-2-pyridyl) ethoxy] benzyl} -2,4-thiazolidinedione hydrochloride
JP2006188582A (en) Novel pyrazolone compound and merocyanine dye using the same
CA1301753C (en) Process for preparing histamine h_-antagonist and intermediates used in such process
JP2001261647A5 (en)
JP3338872B2 (en) Method for producing 1,2-benzisothiazolinone compound
CN110423215B (en) Chalcone pyridine salt and preparation method and application thereof
JP4004082B2 (en) Method for producing cyclic nitroguanidine derivatives
JP3496979B2 (en) Process for producing substituted indole-3-acetic acid compound and substituted benzofuranyl-3-acetic acid compound
JP3711625B2 (en) Method for producing 1H-pyrazolo [3,2-c] -1,2,4-triazole compound
JP2654057B2 (en) Method for producing N, N-disubstituted hydrazine
JP2563231B2 (en) Method for synthesizing 1H-pyrazolo [1,5-b] -1,2,4-triazole derivative
JP3013760B2 (en) Method for producing 4-hydroxy-2-pyrrolidone
JP2986467B2 (en) Method for producing azo compound
US6562979B1 (en) Process for the preparation of substituted benzisothiazole compounds
JPH07228556A (en) Production of 2-aminobenzyl alcohol derivative
JPH04270272A (en) Method for producing aminoalkylmorpholine derivatives
JP3961049B2 (en) 3-Amino-4- (1-hydroxyalkyl) pyrazoline compound, method for producing the same and method for producing the same
CA1207796A (en) Intermediates for the preparation of 4-phenyl-1,3- benzodiazepins and methods for preparing the intermediates
JPH05287210A (en) Production of azomethine dye and indoaniline dye